News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
865,109 Results
Type
Article (87637)
Company Profile (824)
Press Release (776632)
Multimedia
Podcasts (182)
Webinars (28)
Section
Business (233146)
Career Advice (4142)
Deals (39825)
Drug Delivery (141)
Drug Development (91313)
Employer Resources (203)
FDA (18319)
Job Trends (17412)
News (397592)
Policy (39935)
Tag
Academia (3006)
Academic (2)
Accelerated approval (21)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (155)
Alzheimer's disease (1717)
Antibody-drug conjugate (ADC) (283)
Approvals (18387)
Artificial intelligence (554)
Autoimmune disease (121)
Automation (32)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (177)
Biotechnology (487)
Bladder cancer (143)
Brain cancer (56)
Breast cancer (545)
Cancer (4385)
Cardiovascular disease (389)
Career advice (3563)
Career pathing (39)
CAR-T (264)
CDC (57)
Cell therapy (731)
Cervical cancer (34)
Clinical research (76131)
Collaboration (1515)
Company closure (4)
Compensation (1008)
Complete response letters (64)
COVID-19 (2968)
CRISPR (92)
C-suite (679)
Cystic fibrosis (144)
Data (5321)
Decentralized trials (2)
Denatured (66)
Depression (125)
Diabetes (480)
Diagnostics (7134)
Digital health (41)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (258)
Drug pricing (201)
Drug shortages (36)
Duchenne muscular dystrophy (215)
Earnings (99830)
Editorial (57)
Employer branding (25)
Employer resources (173)
Events (134003)
Executive appointments (1004)
FDA (21022)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (21)
Funding (1365)
Gene editing (197)
Generative AI (54)
Gene therapy (594)
GLP-1 (1059)
Government (5404)
Grass and pollen (8)
Guidances (377)
Healthcare (20941)
HIV (54)
Huntington's disease (42)
IgA nephropathy (76)
Immunology and inflammation (268)
Immuno-oncology (27)
Indications (65)
Infectious disease (3230)
Inflammatory bowel disease (196)
Inflation Reduction Act (16)
Influenza (107)
Intellectual property (207)
Interviews (816)
IPO (17937)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (87)
Layoffs (651)
Leadership (37)
Legal (10153)
Liver cancer (94)
Longevity (14)
Lung cancer (623)
Lymphoma (305)
Machine learning (35)
Management (66)
Manufacturing (704)
MASH (163)
Medical device (14945)
Medtech (14982)
Mergers & acquisitions (22837)
Metabolic disorders (1251)
Multiple sclerosis (147)
NASH (23)
Neurodegenerative disease (266)
Neuropsychiatric disorders (78)
Neuroscience (2856)
NextGen: Class of 2025 (7703)
Non-profit (5098)
Now hiring (60)
Obesity (596)
Opinion (321)
Ovarian cancer (149)
Pain (176)
Pancreatic cancer (189)
Parkinson's disease (256)
Partnered (32)
Patents (446)
Patient recruitment (362)
Peanut (58)
People (66494)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23487)
Phase II (33041)
Phase III (24906)
Pipeline (3470)
Policy (312)
Postmarket research (3554)
Preclinical (10618)
Press Release (72)
Prostate cancer (218)
Psychedelics (52)
Radiopharmaceuticals (284)
Rare diseases (734)
Real estate (7431)
Recruiting (80)
Regulatory (28311)
Reports (65)
Research institute (2709)
Resumes & cover letters (651)
Rett syndrome (21)
RNA editing (16)
RSV (80)
Schizophrenia (144)
Series A (222)
Series B (168)
Service/supplier (30)
Sickle cell disease (87)
Special edition (26)
Spinal muscular atrophy (171)
Sponsored (42)
Startups (4322)
State (2)
Stomach cancer (18)
Supply chain (106)
Tariffs (96)
The Weekly (114)
Vaccines (1079)
Venture capital (74)
Weight loss (417)
Women's health (69)
Worklife (21)
Date
Today (56)
Last 7 days (638)
Last 30 days (3639)
Last 365 days (33381)
2025 (30645)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (83)
Alaska (7)
Arizona (316)
Arkansas (14)
Asia (51164)
Australia (8999)
California (10424)
Canada (3059)
China (988)
Colorado (440)
Connecticut (470)
Delaware (301)
Europe (117698)
Florida (1525)
Georgia (340)
Hawaii (3)
Idaho (68)
Illinois (854)
India (59)
Indiana (504)
Iowa (21)
Japan (350)
Kansas (130)
Kentucky (40)
Louisiana (28)
Maine (81)
Maryland (1371)
Massachusetts (7743)
Michigan (331)
Minnesota (608)
Mississippi (6)
Missouri (129)
Montana (34)
Nebraska (27)
Nevada (112)
New Hampshire (81)
New Jersey (2858)
New Mexico (32)
New York (2795)
North Carolina (1498)
North Dakota (10)
Northern California (4866)
Ohio (319)
Oklahoma (22)
Oregon (51)
Pennsylvania (2136)
Puerto Rico (20)
Rhode Island (47)
South America (1656)
South Carolina (57)
South Dakota (1)
Southern California (3992)
Tennessee (160)
Texas (1630)
United States (38045)
Utah (313)
Vermont (1)
Virginia (265)
Washington D.C. (85)
Washington State (874)
West Virginia (4)
Wisconsin (107)
Wyoming (2)
There are 865,109 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cardiovascular disease
Bayer Sets Up Redemption Arc for Anticoagulant With ‘Surprisingly Positive’ Phase III Data
Asundexian’s Phase III win could also bode well for Bristol Myers Squibb, which is also developing a Factor XIa inhibitor called milvexian for stroke prevention, analysts said.
November 24, 2025
·
2 min read
·
Tristan Manalac
Regulatory
FDA Frictions Continue as White House Denies Promotion to Makary’s Aide
November 24, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Bristol Myers Squibb to Host Hematology-Focused Investor Event
November 24, 2025
·
1 min read
Press Releases
Merck Data to be Presented at ASH 2025 Annual Meeting Showcase Continued Advancements in Hematology Pipeline and Novel Therapeutic Approaches
November 24, 2025
·
10 min read
Press Releases
Enlivex Announces Positive 6-Month Topline Data –Demonstrating Durable and Persistent Pain Reduction and Improved Function in Primary Age-Related Patients with Moderate to Severe Knee Osteoarthritis
November 24, 2025
·
8 min read
Press Releases
IDEAYA Biosciences to Participate in Upcoming December 2025 Investor Relations Events
November 24, 2025
·
2 min read
Press Releases
Amphastar Pharmaceuticals to Present at the 37th Annual Piper Sandler Healthcare Conference
November 24, 2025
·
3 min read
Press Releases
Rakovina Therapeutics Inc. Announces Presentation of Second Abstract at the 2025 Society for Neuro-Oncology Annual Meeting
November 24, 2025
·
4 min read
Press Releases
Scilex Holding Company Announces Exercise of Warrants for $20.3 Million Gross Proceeds
November 24, 2025
·
9 min read
Press Releases
Zymeworks Announces Participation in Upcoming December 2025 Investor Conferences
November 24, 2025
·
2 min read
1 of 86,511
Next
